In this episode, the P4A team review all the key events of the year 2020 in the orphan drug, cell and gene therapy world. The emergence of COVID-19 pandemic has caused disruption but also opportunities for the biotech industry. From change in regulations, new stakeholder collaborations to impact of Brexit and US drug pricing reforms, a full round up of 2020. So do listen in!
Presenter and Contributors: Sophie Schmitz and Akshay Kumar
Producer: Aparna Krishnan
Create your
podcast in
minutes
It is Free